Application of Fragment-Based Drug Discovery to Versatile Targets

Front Mol Biosci. 2020 Aug 5:7:180. doi: 10.3389/fmolb.2020.00180. eCollection 2020.

Abstract

Fragment-based drug discovery (FBDD) is a powerful method to develop potent small-molecule compounds starting from fragments binding weakly to targets. As FBDD exhibits several advantages over high-throughput screening campaigns, it becomes an attractive strategy in target-based drug discovery. Many potent compounds/inhibitors of diverse targets have been developed using this approach. Methods used in fragment screening and understanding fragment-binding modes are critical in FBDD. This review elucidates fragment libraries, methods utilized in fragment identification/confirmation, strategies applied in growing the identified fragments into drug-like lead compounds, and applications of FBDD to different targets. As FBDD can be readily carried out through different biophysical and computer-based methods, it will play more important roles in drug discovery.

Keywords: drug discovery; fragment-based drug discovery; lead design; screening; structural biology.

Publication types

  • Review